Building an effective drug forecasting model today requires a revamped approach.
Peter Dillman
Advertisement
Articles by Peter Dillman
Advertisement
Latest Updated Articles
A Forecasting Rx for Pharmacy Benefit ManagersPublished: December 12th 2014 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
